Avila COM, González PL, Telles CML, Espinosa EE, Hernández PC, Ramón RLG, Izquierdo CL, Mustelier CG, Roque GW

Language: Spanish
References: 26
Page: 68-73
PDF size: 102.15 Kb.

ABSTRACT

Chronic myeloid leukemia (CML) is a clonal dysfunction with easy diagnosis since more than 95 % of the leukemia cells present a citogenetic chromosome Philadelphia (Ph) anomaly. The pregnancy has no adverse effect on the illness, but the leucoestasis potentially can commit the placental circulation and cause underweight born, premature birth and the increase of mortality. The imatinib mesylate is the first line therapy for the disease but there are numerous reports about its teratogenic action. The alpha-interferon is the drug of election for treatment during pregnancy. Two patients with CML and pregnancy treated with alpha-interferon are described. The first one treated at diagnosis and the second one after 3 years of treatment with imatinib mesylate which was suspended one month before. The two pregnancies developed satisfactorily same as the fetuses and two children were born with good vitality and healthy with normal psychomotor development.

REFERENCES

1. Buyukbayrak EE, Ergen B, Karsidag YK, Kars B, Turan C, Argon D. Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report. Arch Gynecol Obstet. 2008 Aug;278(2):161-3.

2. Kurzrock R, Kantarjian HM, Druker BJ, Druker BJ, Talpaz M. Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med. 2003 May 20;138(10):819-30.

3. Goldman JM, Melo JV. Chronic myeloid leukemia-advances in biology and new approaches to treatment. N Engl J Med. 2003 Oct 9;349(15):1451-64.

4. Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood. 2000 Nov 15;96(10):3343-56.

5. Azarbashi MS, Smith MR, Karanes C, Zielinski I, Bishop CR. Successful management of Ph chromosome chronic myelogenous leukemia with leukapheresis during pregnancy. Am J Hematol 1991 Nov;38(3):235-7.

6. Barbui T, Finazzi G. Myeloproliferative Disease in Pregnancy and Other Management Issues. Hematology Am Soc Hematol Educ Program. 2006:246-52.

7. Choudhary DR, Mishra P, Kumar R, Mahapatra M, Choudhry VP. Pregnancy on imatinib: Fatal outcome with meningocele. Ann Oncol. 2006 Jan;17(1):178-9.

8. Ault P, Kantarjian H, O'Brien S, Faderl S, Beran M, Rios MB, et al. Pregnancy among patients with chronic myeloid leukemia treated with imatinib. J Clin Oncol. 2006 Mar 1;24(7):1204-8.

9. Pye SM, Cortes J, Ault P, Hatfield A, Kantarjian H, Pilot R, et al. The effects of imatinib on pregnancy outcome. Blood. 2008 Jun 15;111(12):5505-8.

10. Hernández-Ramírez Porfirio. Interferón: ave fénix en el tratamiento de la leucemia mieloide crónica. Rev Cubana Hematol Inmunol Hemoter [revista en la Internet]. 2012 Sep [citado 2012 Dic 01];28(3):226-34. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 02892012000300004&lng=es

11. Kiladjian JJ, Mesa RA, Hoffman R. The renaissance of interferon therapy for the treatment of myeloid malignancies. Blood. 2011 May 5;117(18):4706-15.

12. Simonsson B, Hjorth-Hansen H, Bierrum OW, Porkka K. Interferon alpha for the treatment of chronic myeloid leukemia. Curr Drug Targets. 2011 Mar 1;12(3):420-8.

13. Tartas NE, Foncuberta MC, Avalos JC. Tratamiento de las neoplasias hematológicas en el embarazo. Medicina (B Aires). 2007;67(6 Pt 2):729-36.

14. Regierer AC, Schulz CO, Kuehnhardt D, Flath B, Possinger K. Am J Hematol. 2006 Feb;81(2):149-50.

15. Kumar S, Apostolova M, Woolley PV. A case of chronic myelogenous leukemia in pregnancy characterized by a complex translocation t(9;22;11) (q34;q11.2;q13). Hematol Rep. 2011 Oct 19;3(3):e27.

16. Shapira T, Pereg D, Lishner M. How I treat acute and chronic leukemia in pregnancy. Blood Rev. 2008 Sep;22(5):247-59.

17. Conchon M, Sanabani SS, Bendit I, Santos FM, Serpa M, Dorliac-Llacer PE. Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study.J Hematol Oncol. 2009 Oct 6;2:42.

18. Ali R., Ozkalemkas F, Ozkocaman V, Ozcelik T, Ozan U, Kimya Y, et al. Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with Leukapheresis during pregnancy: a case report and review of the literature. Journal of Clinical Oncology. 2004;34(4):215-7.

19. Ault P, Cortes J. Planned Pregnancy for a Patient with Chronic Myeloid Leukemia. Internet J Oncol. 2010 [consultado: 1 de diciembre de 2012];7(2). DOI: 10.5580/bea. Disponible en: http://archive.ispub.com/journal/the-internet-journalof- oncology/volume-7- number-2/planned-pregnancy-for-a-patient-with-chronicmyeloid- leukemia.html#sthash.4JR5u3hK.dpbs

20. Pavlovsky C, Giere I, Van Thillo G. Planned pregnancy in a chronic myeloid leukemia patient in molecular remission. Case Rep Hematol. 2012;2012:624590. doi: 10.1155/2012/624590.

21. Celiloglu M, Altunyurt S, Undar B. Hydroxyurea treatment for chronic myeloid leukemia during pregnancy. Acta Obstet Gynecol Scand. 2000 Sep;79(9):803-4.

22. Fadilah SA, Ahmad-Zailani H, Soon-Keng C, Norlaila M. Successful treatment of chronic myeloid leukemia during pregnancy with Hydroxyurea. Leukemia. 2002 Jun;16(6):1202-3.

23. Garderet L, Santacruz R, Barbu V, van den Akker J, Carbonne B, Gorin NC. Two successful pregnancies in a chronic myeloid leukemia patient treated with imatinib. Haematologica. 2007 Jan;92(1):e9-10.

24. Ali R, Ozkalemkas F, Ozcelik T, Ozkocaman V, Ozkan A. Imatinib and Pregnancy. J Clin Oncol. 2006 Aug 24(23):3812-3.

25. Conchon M, Sanabani SS, Serpa M, Novaes MM, Nardinelli L, Ferreira PB, et al. Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy. Adv Hematol. 2010;2010:136252. doi:10.1155/2010/136252.

26. Oweini H, Mahfouz RA, Bazarbachi A. Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib. Arch Gynecol Obstet. 2011 Jan;283(1):133-4.